As attendees tuned into their screens, Dr. Elizabeth Jaffee began her presentation Pancreatic Cancer Is PRIMED to Become an Immunologic Disease. With a full house of Zoomers, the Deputy Director of T…
Meenhard Herlyn, D.V.M., D.Sc., is known internationally as one of the fathers of melanoma research. As the founder of The Wistar Institute Melanoma Research Center, he has led the way with breakthro…
Recently, The Wistar Institute created a virtual tour of our Montaner Lab which focuses on infectious disease research such as HIV through highly collaborative regional and international projects. We…
A conversation with the Lieberman Lab delves into how EBV can trigger MS and potential therapeutic solutions that can be developed with this knowledge. Epstein-Barr virus (EBV) is ubiquitous, establi…
Dr. Laura Garcia Gerique, postdoctoral fellow in the Nefedova lab, and Sarah Offley, graduate student in Gardini lab, are winners of the 2022 Annual Rugart Family Awards. This annual event, sponsored…
The team identified the metabolite TMAO drives immune activation in the tumor microenvironment and boosts response to immune checkpoint blockade therapy in pancreatic cancer. Rahul S. Shinde, D.V.M…
With just over a year at The Wistar Institute under their respective scientific belts, innovator-scientists Amelia Escolano, Ph.D., and Daniel Claiborne, Ph.D., have been pushing the scientific envel…
Vaccines are a crucial public health tool in its’ arsenal against diseases. Resurgences of diseases long thought eradicated are popping up decades later in sewage waters here and abroad, and we’ve wi…
This Q&A offers a behind the science peek into some of the long-term effects of COVID on the body influenced by the gut microbiome. In a paper published in JCI Insight, Mohamed Abdel-Mohsen, Ph.D…
On August 4, The Wistar Institute hosted a ceremony celebrating the 2022 graduates of the Biomedical Technician Training (BTT) Program and Fox Biomedical Research Technician (BRT) Apprenticeship. The…
